Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Comparison of health-related quality of life with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil chemotherapy regimens as first-line systemic therapy in locally advanced inoperable or metastatic gastric or gastro-esophageal junction adenocarcinoma: A prospective study from South India ; volume:07 ; number:01 ; year:2018 ; pages:11-15
South Asian journal of cancer ; 07, Heft 01 (2018), 11-15
- Beteiligte Personen und Organisationen
-
Babu, K. Govind
Chaudhuri, Tamojit
Lakshmaiah, K. C.
Dasappa, Lokanatha
Jacob, Linu Abraham
Suresh Babu, M. C.
Rudresha, A. H.
Lokesh, K. N.
Rajeev, L. K.
- DOI
-
10.4103/sajc.sajc_8_17
- URN
-
urn:nbn:de:101:1-2021021720403618648083
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Babu, K. Govind
- Chaudhuri, Tamojit
- Lakshmaiah, K. C.
- Dasappa, Lokanatha
- Jacob, Linu Abraham
- Suresh Babu, M. C.
- Rudresha, A. H.
- Lokesh, K. N.
- Rajeev, L. K.
Ähnliche Objekte (12)
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer (THE TAX 324 trial)
Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma
Auswertung einer Chemotherapie-Studie mit Cisplatin und 5-Fluorouracil [Fluorouracil] bei Patienten mit fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereiches
Adjuvante Chemotherapie mit Cisplatin und 5-Fluorouracil [Fluorouracil] als einarmige prospektive Therapiestudie am Plattenepithelkarzinom von Lippen, Mundhöhle und Oropharynx
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer (THE TAX 324 trial)
Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma
Auswertung einer Chemotherapie-Studie mit Cisplatin und 5-Fluorouracil [Fluorouracil] bei Patienten mit fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereiches
Adjuvante Chemotherapie mit Cisplatin und 5-Fluorouracil [Fluorouracil] als einarmige prospektive Therapiestudie am Plattenepithelkarzinom von Lippen, Mundhöhle und Oropharynx
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial
Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer
Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
Vergleich der Induktionschemotherapie mit Cisplatin-5-Fluorouracil versus Carboplatin-5-Fluorouracil bei fortgeschrittenen Kopf-Hals-Plattenepithelkarzinomen
A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer (THE TAX 324 trial)
Head and neck irradiation modulates pharmacokinetics of 5-fluorouracil and cisplatin
Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinoma
Auswertung einer Chemotherapie-Studie mit Cisplatin und 5-Fluorouracil [Fluorouracil] bei Patienten mit fortgeschrittenen Plattenepithelkarzinomen des Kopf-Hals-Bereiches
Adjuvante Chemotherapie mit Cisplatin und 5-Fluorouracil [Fluorouracil] als einarmige prospektive Therapiestudie am Plattenepithelkarzinom von Lippen, Mundhöhle und Oropharynx
Definitive concurrent chemoradiotherapy with docetaxel plus cisplatin versus 5-fluorouracil plus cisplatin in patients with esophageal squamous cell carcinoma: long-term follow-up results of a phase II randomized controlled trial